Latus Bio
About Latus Bio
Latus Bio is a biotechnology company focused on developing gene therapy candidates that use precision delivery to treat CNS disorders. by leveraging high-throughput screened AAV capsids, the company aims to target specific tissues to improve safety and efficacy for patients. its leadership emphasizes translational medicine from bench to bedside, advancing CNS-focused gene therapies with a goal of reducing the need for frequent administrations.
Recent News
Latus Bio Secures $97 Million Series A to Scale Gene‑Therapy Access
ASGCT 2026: Beverly Davidson Offers Vehicle and Route for Huntington’s Disease Gene Therapy
Latus Bio Raises $97M to Expand Gene Therapy Pipeline
Follow the Money: AI Drug Design Engine, Treating Multiple Myeloma, Quantum Healthcare Platform